Funded Startups in Los Gatos
Funded rounds listed for Los Gatos run from 2020-02-18 (iMerit, AI) to 2025-10-04 (Mulltiply, Pre-Seed), with the most recent entry at the end of that window.
Funded rounds listed for Los Gatos run from 2020-02-18 (iMerit, AI) to 2025-10-04 (Mulltiply, Pre-Seed), with the most recent entry at the end of that window. The disclosed amounts show one clear outlier: AmplifyMD’s $20M (2025-09-26) sits among higher rounds, but ServiceUp at $55M (2025-07-09) is the only disclosed deal above $50M, dwarfing the next-largest disclosed amounts such as Elsa’s $23M (2023-09-12) and iMerit’s $20M (2020-02-18).
The list also clusters temporally around 2024–2023, with multiple rounds in October 2024 (ApertureData $5M on 2024-10-10; Cerebelly $3M on 2024-10-10) and in 2023 across Q3–Q4 (Elsa $23M on 2023-09-12; Advanced NanoTherapies $4M on 2023-08-22; aiXplain $8M on 2023-04-26). Sector-wise, Artificial Intelligence (ApertureData, Rapid Silicon, aiXplain-adjacent via “Administrative Services” does not apply; Aginity and iMerit) appears repeatedly, while several entries have “Series Unknown” or “undisclosed” amounts (Blue Planet on 2024-01-16 is undisclosed; SkinSpirit is undisclosed), which limits stage-to-size comparisons for part of the dataset.
Most recent rounds
24 shownRelated listings
Frequently asked
Which disclosed round is the standout outlier in this Los Gatos list, and how far above the rest is it?
ServiceUp’s $55M on 2025-07-09 is the only disclosed round above $50M in these 24 entries, while the next-largest disclosed amounts are much lower (e.g., Elsa at $23M on 2023-09-12 and AmplifyMD at $20M on 2025-09-26).
How concentrated are the rounds in time—do multiple companies close in the same narrow windows?
October 2024 has a mini-cluster with ApertureData ($5M) and Cerebelly ($3M) both dated 2024-10-10. 2023 also shows density across Q3–Q4, including Advanced NanoTherapies ($4M) on 2023-08-22 and Elsa ($23M) on 2023-09-12, before additional 2023 deals like aiXplain ($8M) on 2023-04-26.
Are there repeated sectors that would be worth prioritizing in outreach or diligence?
Artificial Intelligence appears multiple times through ApertureData (AI, $5M on 2024-10-10), Rapid Silicon (AI, $15M on 2023-01-09), Aginity (AI, $4M on 2022-04-12), and iMerit (AI, 2020-02-18 at $20M). Health Care is also repeated (AmplifyMD $20M on 2025-09-26; Venova Medical $10M on 2024-08-15; Advanced NanoTherapies $4M on 2023-08-22; Evanostics $600K on 2020-11-04).
What portion of entries have non-standard funding visibility (Series Unknown or undisclosed amounts), and does it affect cross-company comparisons?
At least two entries show undisclosed amounts (Blue Planet on 2024-01-16 and SkinSpirit on 2022-10-20), and several others use “Series Unknown”/blank stage labels (e.g., Venova Medical $10M with “Series Unknown” on 2024-08-15; Blue Planet is “Series Unknown” with undisclosed amount; cyberManor and Playper have blank stage fields). This means stage-to-size patterns are clearest only where both stage and amount are specified.
Which entries closed within the most recent 90 days of the latest date shown (2025-10-04), and what does their size distribution look like?
Within ~90 days of 2025-10-04, the list includes Mulltiply ($300K on 2025-10-04), AmplifyMD ($20M on 2025-09-26), ServiceUp ($55M on 2025-07-09), and (from the same recent window) entries like ApertureData are outside the 90-day band. Even in this tight window, disclosed sizes range from $300K up to $55M (ServiceUp), indicating a wide dispersion rather than one dominant check size.
Are there any unusually small disclosed rounds that contrast with the larger deals, suggesting a broader mix of financing sizes?
The smallest disclosed amount in the shown rows is $30K for Playper on 2024-03-12. That sits far below the typical higher disclosed checks in the list, such as ServiceUp’s $55M (2025-07-09) and Elsa’s $23M (2023-09-12), signaling that the dataset mixes early, smaller disclosed financings with much larger later-stage deals.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.